THE IDENTIFICATION OF L-ALPHA-AMINO-DELTA-HYDROXYVALERIC ACID AND L-HOMOSERINE IN JACK BEAN SEEDS (CANAVALIA ENSIFORMIS).

J. Thompson,C. J. Morris,G. E. Hunt

IF: 5.485

1964-04-01

Journal of Biological Chemistry

Abstract:

What problem does this paper attempt to address?

Islet Transplantation Imaging In Vivo

Lei Zheng,Yinghao Wang,Bin Yang,Bo Zhang,Yulian Wu

DOI: https://doi.org/10.2147/DMSO.S263253

2020-01-01

Abstract:Although islet transplantation plays an effective and powerful role in the treatment of diabetes, a large amount of islet grafts are lost at an early stage due to instant blood-mediated inflammatory reactions, immune rejection, and fl-cell toxicity resulting from immunosuppressive agents. Timely intervention based on the viability and function of the transplanted islets at an early stage is crucial. Various islet transplantation imaging techniques are available for monitoring the conditions of post-transplanted islets. Due to the development of various imaging modalities and the continuous study of contrast agents, noninvasive islet transplantation imaging in vivo has made great progress. The tracing and functional evaluation of transplanted islets in vivo have thus become possible. However, most studies on contrast agent and imaging modalities are limited to animal experiments, and long-term toxicity and stability need further evaluation. Accordingly, the clinical application of the current achievements still requires a large amount of effort. In this review, we discuss the contrast agents for MRI, SPECT/PET, BLI/FI, US, MPI, PAI, and multimodal imaging. We further summarize the advantages and limitations of various molecular imaging methods.
Detection of cytoskeleton antibodies on vinblastine-treated mononuclear cells.

D. Zauli,C. Crespi,F. B. Bianchi,E. Pisi

1986-07-01

Abstract:
Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging

Nathaniel Chan,Andre Obenaus,Annie Tan,Naoaki Sakata,John Mace,Ricardo Peverini,Richard Chinnock,Lawrence C Sowers,Eba Hathout

DOI: https://doi.org/10.4161/isl.1.3.9862

Islets

Abstract:Fifteen thousand youths are diagnosed yearly with type 1 diabetes mellitus. Pancreatic islet transplantation has been shown clinically to provide short-term (~1 year) insulin independence. However, challenges associated with early vascularization of transplanted islet grafts and long-term islet survival remain. We utilized dynamic contrast enhanced magnetic resonance imaging (DCE MRI) to monitor neovascularization of islets transplanted into the right lobe of the liver in a syngeneic mouse model system. The left lobe received no islets and served as a control. DCE data were analyzed for temporal dynamics of contrast (gadolinium) extravasation and the results were fit to a Tofts two-compartment exchange model. We observed maximal right lobe enhancement at seven days post-transplantation. Histological examination up to 28 days was used to confirm imaging results. DCE-derived enhancement strongly correlated with immunohistochemical measures of neovascularization. To our knowledge, these results are the first to demonstrate using a FDA approved contrast agent that DCE MRI can effectively and non-invasively monitor the progression of angiogenesis in intraportal islet grafts.
Microarray-based expression analysis of human osteoblast-like cell response to anodized titanium surface

Yeonhee Kim,Jun-Hyeog Jang,Y. Ku,J. Koak,I. Chang,Hyoun-ee Kim,Jae-Bong Lee,S. Heo

DOI: https://doi.org/10.1023/B:BILE.0000018258.58314.5c

2004-03-01

Biotechnology Letters

Abstract:
Dmso_a_263253 3301..3311

Lei Zheng,Yinghao Wang,Bin Yang,Bo Zhang,Yulian Wu

2020-01-01

Abstract:*These authors contributed equally to this work Abstract: Although islet transplantation plays an effective and powerful role in the treatment of diabetes, a large amount of islet grafts are lost at an early stage due to instant bloodmediated inflammatory reactions, immune rejection, and β-cell toxicity resulting from immunosuppressive agents. Timely intervention based on the viability and function of the transplanted islets at an early stage is crucial. Various islet transplantation imaging techniques are available for monitoring the conditions of post-transplanted islets. Due to the development of various imaging modalities and the continuous study of contrast agents, noninvasive islet transplantation imaging in vivo has made great progress. The tracing and functional evaluation of transplanted islets in vivo have thus become possible. However, most studies on contrast agent and imaging modalities are limited to animal experiments, and long-term toxicity and stability need further evaluation. Accordingly, the clinical application of the current achievements still requires a large amount of effort. In this review, we discuss the contrast agents for MRI, SPECT/PET, BLI/FI, US, MPI, PAI, and multimodal imaging. We further summarize the advantages and limitations of various molecular imaging methods.
3D in vivo Magnetic Particle Imaging of Human Stem Cell-Derived Islet Organoid Transplantation Using a Machine Learning Algorithm

Aixia Sun,Hasaan Hayat,Sihai Liu,Eliah Tull,Jack Owen Bishop,Bennett Francis Dwan,Mithil Gudi,Nazanin Talebloo,James Raynard Dizon,Wen Li,Jeffery Gaudet,Adam Alessio,Aitor Aguirre,Ping Wang

DOI: https://doi.org/10.3389/fcell.2021.704483

IF: 5.5

2021-08-12

Frontiers in Cell and Developmental Biology

Abstract:Stem cell-derived islet organoids constitute a promising treatment of type 1 diabetes. A major hurdle in the field is the lack of appropriate in vivo method to determine graft outcome. Here, we investigate the feasibility of in vivo tracking of transplanted stem cell-derived islet organoids using magnetic particle imaging (MPI) in a mouse model. Human induced pluripotent stem cells-L1 were differentiated to islet organoids and labeled with superparamagnetic iron oxide nanoparticles. The phantoms comprising of different numbers of labeled islet organoids were imaged using an MPI system. Labeled islet organoids were transplanted into NOD/scid mice under the left kidney capsule and were then scanned using 3D MPI at 1, 7, and 28 days post transplantation. Quantitative assessment of the islet organoids was performed using the K-means ++ algorithm analysis of 3D MPI. The left kidney was collected and processed for immunofluorescence staining of C-peptide and dextran. Islet organoids expressed islet cell markers including insulin and glucagon. Image analysis of labeled islet organoids phantoms revealed a direct linear correlation between the iron content and the number of islet organoids. The K-means ++ algorithm showed that during the course of the study the signal from labeled islet organoids under the left kidney capsule decreased. Immunofluorescence staining of the kidney sections showed the presence of islet organoid grafts as confirmed by double staining for dextran and C-peptide. This study demonstrates that MPI with machine learning algorithm analysis can monitor islet organoids grafts labeled with super-paramagnetic iron oxide nanoparticles and provide quantitative information of their presence in vivo .

cell biology,developmental biology
Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.

Bo Zhang,Biao Jiang,Ying Chen,Hai Huang,Qiuping Xie,Muxing Kang,Hui Zhang,Chuanxin Zhai,Yulian Wu

DOI: https://doi.org/10.1002/cmmi.461

2012-01-01

Contrast Media & Molecular Imaging

Abstract:Islets can be visualized on MRI by labeling with superparamagnetic contrast agent during the transplantation procedure. However, whether the signal intensity reflects the cell number and cellular viability has not been determined. We used a self-synthesized novel superparamagnetic contrast agent polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles (PVP-SPIO) to label beta-TC-6 cells (a mouse insulinoma cell line) or primary islets with commercial Feridex as a control. The labeling efficiency of two agents was compared by Prussian blue staining, intracellular iron content determination and MR scanning. Cells were exposed to hypoxia, high-glucose or exogenous H2O2 stimulation before/after PVP-SPIO labeling. Normal and injured cells were also transplanted into renal subcapsule. A clinically used 3.0?T MR scan was performed in vitro and 24?h post-transplantation to investigate the correlation between cellular viability and signal. Our PVP-SPIO displayed superior biocompatibility and magnetic properties. All of the cells could be labeled at 100?mu g/ml iron concentration after 24?h incubation. At 100?mu g/ml iron concentration, 1?x?105 beta cells labeled with PVP-SPIO could already be visualized in vitro by MRI, less than the detection threshold of Feridex. There existed a linear correlation between the number of labeled cells and R2 value on the T2-weighted images. The signal intensity and the intracellular iron content declined along with the decreased viability of labeled cells. There was also a significant difference in signal intensity between injured and normal labeled cells after transplantation. From these results, we concluded that PVP-SPIO possessed superior cell labeling efficiency, and beta cells could be labeled without compromising viability and function. The signal intensity on MRI might be a useful predictor to evaluate the number and the viability of PVP-SPIO-labeled cells. Copyright (c) 2012 John Wiley & Sons, Ltd.
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Kai Wang,Xi Wang,Cheng-sheng Han,Liang-yi Chen,Ying Luo

DOI: https://doi.org/10.3791/54995

2017-01-01

Journal of Visualized Experiments

Abstract:Islet transplantation has been clinically proven to be effective at treating type 1 diabetes. However, the current intrahepatic transplantation strategy may incur acute whole blood reactions and result in poor islet engraftment. Here, we report a robust protocol for the transplantation of islets at the extrahepatic transplantation site-the epididymal fat pad (EFP)-in a diabetic mouse model. A protocol to isolate and purify islets at high yields from C57BL/6J mice is described, as well as a transplantation method performed by seeding islets onto a decellularized scaffold (DCS) and implanting them at the EFP site in syngeneic C57BL/6J mice rendered diabetic by streptozotocin. The DCS graft containing 500 islets reversed the hyperglycemic condition within 10 days, while the free islets without DCS required at least 30 days. The normoglycemia was maintained for up to 3 months until the graft was explanted. In conclusion, DCS enhanced the engraftment of islets into the extrahepatic site of the EFP, which could easily be retrieved and might provide a reproducible and useful platform for investigating the scaffold materials, as well as other transplantation parameters required for a successful islet engraftment.
MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model

Kieran Purich,Haolei Cai,Bin Yang,Zhihao Xu,Anthony G. Tessier,Adnan Black,Ryan W. Hung,Eric Boivin,Baoyou Xu,Ping Wu,Bo Zhang,Dong Xin,Biagio Gino Fallone,Ray Rajotte,Yulian Wu,Gina R. Rayat

DOI: https://doi.org/10.1111/xen.12720

2022-01-01

Xenotransplantation

Abstract:Islet transplantation is a potential treatment option for certain patients with type 1 diabetes; however, it still faces barriers to widespread use, including the lack of tools to monitor islet grafts post-transplantation. This study investigates whether labeling neonatal porcine islets (NPI) with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles (PVP-SPIO) affects their function, and whether this nanoparticle can be utilized to monitor NPI xenografts with magnetic resonance imaging (MRI) in a mouse model. In vitro, PVP-SPIO-labeled NPI in an agarose gel was visualized clearly by MRI. PVP-SPIO-labeled islets were then transplanted under the kidney capsules of immunodeficient nondiabetic and diabetic mice. All diabetic mice that received transplantation of PVP-SPIO-labeled islets reached normoglycemia. Grafts appeared as hypo-intense areas on MRI and were distinguishable from the surrounding tissues. Following injection of spleen cells from immunocompetent mice, normoglycemic recipient mice became diabetic and islet grafts showed an increase in volume, accompanied by a mixed signal on MRI. Overall, this study demonstrates that PVP-SPIO did not affect the function of NPI that PVP-SPIO-labeled islets were easily seen on MRI, and changes in MRI signals following rejection suggest a potential use of PVP-SPIO-labeled islets to monitor graft viability.
Tracking transplanted pancreatic islet cells in rats using magnetic resonance imaging

Bijing Zhou,HE Hui-jin,FENG Xiao-yuan,Shanzhong Zhang,YANG Yan-mei

DOI: https://doi.org/10.3969/j.issn.1672-8467.2009.06.002

2009-01-01

Abstract:Objective To track superparamagnetic iron oxide(SPIO)-labeled pancreatic islet cells in rats using 3.0T magnetic resonance imaging(MRI),and to detect the survival and rejection of grafts after transplantation. Methods Twenty male Wistar rats and 5 male Lewis rats were included in the study.SPIO-labeled pancreatic islet cells were tracked using a GE 3.0T Signa Excite MRI scanner with an animal coil.The images of SPIO-labeled islet cells in rats after transplantation were compared with those of the unlabeled ones.FSE T2WI sequence and GRE T2*WI sequence were used for the detection.The sensitivity of images for detection of grafts was also compared.SPIO-labeled pancreatic islet cells isolated from Wistar and Lewis rats were transplanted into the liver of Wistar rats.Afterwards,the survival and rejection of islet cells were observed sequentially in these two growps.The rats in the syngeneic group were sacrificed 3 months post-transplantation,while the rats in the allogeneic group were sacrificed 3 weeks post-transplantation.MRI of the grafts were correlated with the pathological results. Results SPIO-labeled pancreatic islet cells were seen on MRI as distinct homogenous,hypointense spots in the liver.GRE T2*WI were more sensitive to the detection of SPIO-labeled islet cells than FSE T2WI.The relative count of hypointense spots in the syngeneic group were(90.03±9.52)%,(92.87±18.21)% and(86.25±24.81)%,respectively at 1 week,2 weeks and 3 weeks after transplantation,while the relative count in the allogeneic group were(41.40±15.41)%,(33.41±14.01)% and(23.58±16.78)%,respectively.The difference between these counts was statistically significant(P<0.01).Iron particles were detected only in the SPIO-labeled cells.Three months post-transplantation,the grafts were found well-preserved in the liver of the rats of the syngeneic group,while only a few grafts were found in that of the allogeneic group. Conclusions MRI can be used to track SPIO-labeled islet cells in vivo,and has significant value in detecting the survival and rejection of grafts after transplantation in rats.
A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using 111In-exendin

Wietske Woliner-van der Weg,Laura N. Deden,Antoi P. W. Meeuwis,Maaike Koenrades,Laura H. C. Peeters,Henny Kuipers,Geert Jan Laanstra,Martin Gotthardt,Cornelis H. Slump,Eric P. Visser

DOI: https://doi.org/10.1186/s40658-016-0165-0

2016-12-01

EJNMMI Physics

Abstract:BackgroundQuantitative single photon emission computed tomography (SPECT) is challenging, especially for pancreatic beta cell imaging with 111In-exendin due to high uptake in the kidneys versus much lower uptake in the nearby pancreas. Therefore, we designed a three-dimensionally (3D) printed phantom representing the pancreas and kidneys to mimic the human situation in beta cell imaging. The phantom was used to assess the effect of different reconstruction settings on the quantification of the pancreas uptake for two different, commercially available software packages.Methods3D-printed, hollow pancreas and kidney compartments were inserted into the National Electrical Manufacturers Association (NEMA) NU2 image quality phantom casing. These organs and the background compartment were filled with activities simulating relatively high and low pancreatic 111In-exendin uptake for, respectively, healthy humans and type 1 diabetes patients. Images were reconstructed using Siemens Flash 3D and Hermes Hybrid Recon, with varying numbers of iterations and subsets and corrections. Images were visually assessed on homogeneity and artefacts, and quantitatively by the pancreas-to-kidney activity concentration ratio.ResultsPhantom images were similar to clinical images and showed comparable artefacts. All corrections were required to clearly visualize the pancreas. Increased numbers of subsets and iterations improved the quantitative performance but decreased homogeneity both in the pancreas and the background. Based on the phantom analyses, the Hybrid Recon reconstruction with 6 iterations and 16 subsets was found to be most suitable for clinical use.ConclusionsThis work strongly contributed to quantification of pancreatic 111In-exendin uptake. It showed how clinical images of 111In-exendin can be interpreted and enabled selection of the most appropriate protocol for clinical use.

radiology, nuclear medicine & medical imaging
Characterization of biophysical properties of insulin-producing cells labeled with SPIO-PLL in vitro

Wei-ying WANG,Gang DENG,Ai-mei LI,Jun-hui SUN

DOI: https://doi.org/10.3969/j.issn.1008-794X.2007.02.009

2007-01-01

Abstract:Objective To evaluate the biophysical properties of insulin-producing cells labeled and unlabeled with superparamagnctic iron oxide nanoparticals and poly-L-lysine(SPIO-PLL)in vitro,and then monitor cellular imaging with 1.5 T MR.Methods BMSCs were isolated from tibia and femur of 6～8 weeks normal Spragne-Dawley rats,purified on the basis of their ability to adhere to the matrix,and expanded through their self-renewal.Two-step strategy was adopted with BMSCs induced into insulin-producing cells, After that,the cells were incubated with SPIO-PLL.Prussian blue stain was employed for identifying intracellular irons.Radioimmunology assay was used to measure the insulin secretion by the labeled and unlabeled cells,and later on underwent MR imaging with T_1WI、T_2WI、T_2*WI sequences,Results lntracytoplasmic nanoparticales were stained with Prussian blue possessing insulin-producing cells labeled with SPIO-PLL.The amount of insulin secreted by the labeled and unlabeled ceils had no statistical significant difference.The signal intensity of labeled cells decreased significantly on T_2*WI,as well as the stronger proportional variations for signal intensity.Conclusion Insulin-producing cells can be labelled effectively with SPIO-PLL and be imaged by 1.5 T MRI.(J Intervent Radiol,2007,16:104-108)
Adrenal gland function in the horse: effects of cosyntropin (synthetic) and corticotropin (natural) stimulation.

H. Eiler,D. Goble,J. Oliver

1979-05-01

American Journal of Veterinary Research

Abstract:The plasma concentration of hydrocortisone was determined in mares given either cosyntropin (100 IU, given IV) or corticotropin (200 IU, given IM). Plasma hydrocortisone concentrations of the mares treated with cosyntropin increased by 46%, 57% and 80% at 30, 60, and 120 minutes, respectively, when compared with base-line values; these values returned to base line at 240 minutes. In mares treated with corticotropin, mean plasma hydrocortisone concentrations increased by 42%, 143%, 101% and 155% at 30, 60, 120, and 240 minutes, respectively, when compared with base-line values. Differences in total leukocyte count, total eosinophil count, and plasma concentrations of electrolytes (calcium, sodium, magnesium, potassium) of cosyntropin- and corticotropin-treated mares, and these values in control animals were not significant. Results of the present study indicated that the horse responds to small dosages of cosyntropin (IV) in a prompt and reproducible manner as determined by plasma hydrocortisone values. Response to corticotropin was slow and less consistent. Thus, administration of cosyntropin to the horse, according to test results with paired samples collected (before administration and again at 2 hours after injection), was found to be a prompt and meaningful test of adrenal gland function.
Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas

Theodorus J P Jansen,Sevilay Tokgöz,Mijke Buitinga,Sanne A M van Lith,Lieke Joosten,Cathelijne Frielink,Esther M M Smeets,Martijn W J Stommel,Marion B van der Kolk,Bastiaan E de Galan,Maarten Brom,Marti Boss,Martin Gotthardt

DOI: https://doi.org/10.1186/s13550-024-01159-6

2024-10-15

Abstract:Background: Estimation of beta cell mass is currently restricted to evaluating pancreatic tissue samples, which provides limited information. A non-invasive imaging technique that reliably quantifies beta cell mass enables monitoring of changes of beta cell mass during the progression of diabetes mellitus and may contribute to monitoring of therapy effectiveness. We assessed the specificity of radiolabelled exendin for beta cell mass quantification in humans. Fourteen adults with pancreas tumours were injected with 111In-labeled exendin-4 prior to pancreatic resection. In resected pancreas tissue, endocrine-exocrine ratios of tracer uptake were determined by digital autoradiography and accumulation of 111In-labeled exendin-4 was compared to insulin and GLP-1 receptor staining. Of four participants, abdominal single photon emission computed tomography/computed tomography (SPECT/CT) images were acquired to quantify pancreatic uptake in vivo RESULTS: Tracer uptake was predominantly present in the endocrine pancreas (endocrine-exocrine ratio: 3.6 [2.8-10.8]. Tracer accumulation showed overlap with insulin-positive regions, which overlapped with GLP-1 receptor positive areas. SPECT imaging showed pancreatic uptake of radiolabelled exendin in three participants. Conclusion: Radiolabelled exendin specifically accumulates in the islets of Langerhans in human pancreas tissue. The clear overlap between regions positive for insulin and the GLP-1 receptor substantiate the beta cell specificity of the tracer. Radiolabelled exendin is therefore a valuable imaging agent for human beta cell mass quantification and has the potential to be used for a range of applications, including improvement of diabetes treatment by assessment of the effects of current and novel diabetes therapies on the beta cell mass. Trial registration: ClinicalTrials.gov NCT03889496, registered 26,032,019, URL https://clinicaltrials.gov/study/NCT03889496?term=NCT03889496 . Clinicaltrials: gov NCT04733508, registered 02022021, URL https://clinicaltrials.gov/study/NCT04733508 .
Pressure strengthening: A way to multimegabar static pressures.

Christensen,Ruoff,Rodríguez

DOI: https://doi.org/10.1103/PHYSREVB.52.9121

1995-10-01

Abstract:
In Vitro and in Vivo MR Imaging of Rat Pancreatic Islet Cells

周碧婧,何慧瑾,冯晓源,张善中,杨艳梅

DOI: https://doi.org/10.3321/j.issn:1003-3289.2009.01.012

2009-01-01

Abstract:Objective To track SPIO-labeled cells using MRI in vitro and in vivo,in order to find appropriate parameters and sequence. Methods Pancreatic islet cells of rat were labeled with SPIO combined with PLL by means of receptor-mediated endocytosis,and were scanned on a GE 3.0T Signa Excite MR scanner equipped with an animal coil for a standard T2*-weighted gradient echo sequence. The images of SPIO-labeled cells were compared with that of the unlabeled. Two scan protocols with different resolutions were used to scan the labeled cells. SPIO-labeled and unlabeled cells were transplanted into the rats' liver respectively,and their MR images were compared. FSE T2WI sequence and GRE T2*WI sequence were used to scan the SPIO-labeled cells,and the sensitivity of images was compared. Results Only SPIO-labeled pancreatic islet cells were seen on MRI as distinct hypointense spots both in vitro and in vivo. The SPIO-labeled pancreatic islet cells could be more clearly seen on higher resolution images. GRE T2*WI was more sensitive on the detection of SPIO than FSE T2WI. Conclusion MRI can be used to track SPIO-labeled islet cells both in vitro and in vivo,and provide great value to detect the survival status and rejection of grafts after transplantation.
FALSE-POSITIVE TESTS FOR INTRINSIC-FACTOR ANTIBODY

U. Stenman

DOI: https://doi.org/10.1016/S0140-6736(76)92456-9

IF: 202.731

1976-08-21

The Lancet

Abstract:
The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide

Jing Lv,Yu Pan,Xiao Li,Dengfeng Cheng,Shuai Liu,Hongcheng Shi,Yifan Zhang

DOI: https://doi.org/10.1371/journal.pone.0096833

IF: 3.7

2014-05-07

PLoS ONE

Abstract:OBJECTIVE: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of 125I-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-photon emission computed tomography/computed tomography) imaging of insulinomas.METHODS: Liraglutide was labelled with 125I by the Iodogen method. The labelled 125I-liraglutide compound and insulinoma cells from the INS-1 cell line were then used for in vitro saturation and competitive binding experiments. In addition, in a nude mouse model, the use of 125I-liraglutide for the in vivo small-animal SPECT/CT imaging of insulinomas and the resulting distribution of radioactivity across various organs were examined.RESULTS: The labelling of liraglutide with 125I was successful, yielding a labelling rate of approximately 95% and a radiochemical purity of greater than 95%. For the binding between 125I-liraglutide and the GLP-1 receptor on the surface of INS-1 cells, the equilibrium dissociation constant (Kd) was 128.8 ± 30.4 nmol/L(N = 3), and the half-inhibition concentration (IC50) was 542.4 ± 187.5 nmol/L(N = 3). Small-animal SPECT/CT imaging with 125I-liraglutide indicated that the tumour imaging was clearest at 90 min after the 125I-liraglutide treatment. An examination of the in vivo distribution of radioactivity revealed that at 90 min after the 125I-liraglutide treatment, the target/non-target (T/NT) ratio for tumour and muscle tissue was 4.83 ± 1.30(N = 3). Our study suggested that 125I-liraglutide was predominantly metabolised and cleared by the liver and kidneys.CONCLUSION: The radionuclide 125I-liraglutide can be utilised for the specific imaging of insulinomas, representing a new non-invasive approach for the in vivo diagnosis of insulinomas.

multidisciplinary sciences
Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.

Yi Wang,Keunpoong Lim,Marc Normandin,Xiaojian Zhao,Gary W Cline,Yu-Shin Ding

DOI: https://doi.org/10.1016/j.nucmedbio.2011.07.011

IF: 2.947

2012-01-01

Nuclear Medicine and Biology

Abstract:Glucagon-like peptide 1 (GLP-1) is released in response to food intake and plays an important role in maintaining blood glucose homeostasis. Exendin (9-39), a potent glucagon-like peptide 1 receptor antagonist, has been labeled with In-111 for SPECT imaging. We report here the first radiosynthesis of [(18)F]exendin (9-39) ([(18)F]Ex(9-39)) and an evaluation of its potential as a biomarker for in vivo positron emission tomography (PET) imaging of pancreatic β-cell mass (BCM) in rats.F-18 label was introduced by conjugation of [(18)F]4-fluorobenzaldehyde with an Ex(9-39) derivative containing a 6-hydrazinonicotinyl group on the ε-amine of Lys27. Positron emission tomography imaging was carried out in Sprague-Dawley rats (five control and five streptozotocin-induced diabetic) and BioBreeding diabetes-prone rats (three at 7 weeks and three at 12 weeks) using the high-resolution research tomograph (HRRT) after 0.187 ± 0.084 mCi [(18)F]Ex(9-39) administration. Time-activity curves were obtained from pancreas, liver and kidney. Pancreases were assayed for insulin content after the imaging study.Site-specifically labeled [(18)F]Ex(9-39) was purified on a G15 open column with radiochemical and chemical purities >98%. Positron emission tomography imaging showed pancreatic standardized uptake value (SUV) peaked at 10 min and plateaued by 50 min to the end of scan (240 min). No correlations of pancreatic SUV with postmortem measures of insulin content were seen.[(18)F]Ex(9-39) was successfully prepared and used for PET imaging for the first time to measure pancreatic BCM. The results suggest that derivatization of the Lys27 residue might reduce binding affinity, as evidenced by the absence of specific binding. Exendin analogues radiolabeled at other sites may elucidate the active site required for binding.
The Role of Exendin-4-conjugated Superparamagnetic Iron Oxide Nanoparticles in Beta-Cell-targeted MRI

Bo Zhang,Bin Yang,Chuanxin Zhai,Biao Jiang,Yulian Wu

DOI: https://doi.org/10.1016/j.biomaterials.2013.04.021

IF: 14

2013-01-01

Biomaterials

Abstract:Noninvasive targeted visualization of pancreatic beta cells or islets is becoming the focus of molecular imaging application in diabetes and islet transplantation studies, but it is currently unsuccessful due to the lack of specific beta cell biomarkers. Glucagon-like peptide 1 receptor (GLP-1R) is highly expressed in beta cells and considered as a promising target. We here developed a targeted superparamagnetic iron oxide (SPIO) nanoparticle using GLP-1 analog-exendin-4 which is conjugated to polyethylene glycol coated SPIO (PEG-SPIO). The results demonstrated that exendin-4 functionalized SPIO was able to specifically bind to and internalized by GLP-1R-expressing INS-1 cells, with the higher labeling efficiency than non-targeted nanoparticles. Notably, SPIO-exendin4 could differentially label islets in pancreatic slices or beta cell grafts in vitro. Systemic delivery of SPIO-exendin4 into nude mice bearing s.c. insulinomas (derived from INS-1 cells) leads to the accumulation of the nanoparticles in tumors, generating a strong magnetic resonance imaging contrast detectable by a clinical MRI scanner at field strength of 3.0 T, and the iron deposition in tumors was further confirmed by Prussian blue staining. Furthermore, preliminary biodistribution study indicated that SPIO-exendin4 had a tendency to accumulate in pancreas. Toxicity assessments demonstrated good biocompatibility in vivo. These results suggest that SPIO-exendin4 has potential as molecularly targeted imaging agents for in vivo imaging of insulinoma, and possibly for future beta cell imaging.

THE IDENTIFICATION OF L-ALPHA-AMINO-DELTA-HYDROXYVALERIC ACID AND L-HOMOSERINE IN JACK BEAN SEEDS (CANAVALIA ENSIFORMIS).

Islet Transplantation Imaging In Vivo

Detection of cytoskeleton antibodies on vinblastine-treated mononuclear cells.

Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging

Microarray-based expression analysis of human osteoblast-like cell response to anodized titanium surface

Dmso_a_263253 3301..3311

3D in vivo Magnetic Particle Imaging of Human Stem Cell-Derived Islet Organoid Transplantation Using a Machine Learning Algorithm

Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model

Tracking transplanted pancreatic islet cells in rats using magnetic resonance imaging

A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using 111In-exendin

Characterization of biophysical properties of insulin-producing cells labeled with SPIO-PLL in vitro

Adrenal gland function in the horse: effects of cosyntropin (synthetic) and corticotropin (natural) stimulation.

Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas

Pressure strengthening: A way to multimegabar static pressures.

In Vitro and in Vivo MR Imaging of Rat Pancreatic Islet Cells

FALSE-POSITIVE TESTS FOR INTRINSIC-FACTOR ANTIBODY

The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide

Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.

The Role of Exendin-4-conjugated Superparamagnetic Iron Oxide Nanoparticles in Beta-Cell-targeted MRI